These effects are yet to be confirmed in patients with GBA1-linked disease, but allude to the fact that gut dysfunction, particularly intestinal autophagy defects, may contribute to the development of PD in GBA1 mutation carriers and individuals with GD. The gene discussed is GBA1; the disease is Parkinson disease.